Ambient
Showing 131551–131600 of 146499 results
-
Sarcosine-13C3
Molecular Formula : 13C3H7NO2
-
Sarcosine-d3
Molecular Formula : C3H4D3NO2
-
Sarcosine-d3
Molecular Formula : C3H4D3NO2
-
Sarcosine-d3 Hydrochloride
Molecular Formula : C3 2H3 H4 N O2 . Cl H
-
Sarcosine-d3 Hydrochloride
Molecular Formula : C3 2H3 H4 N O2 . Cl H
-
Sarcosine, Ultrapure
Sarcosine, Ultrapure
-
Sarcosine, Ultrapure
Sarcosine, Ultrapure
-
Sarcosine, Ultrapure
Sarcosine, Ultrapure
-
Sarmentine
Molecular Formula : C14 H23 N O
-
Sarmentine
Molecular Formula : C14 H23 N O
-
Sarmentine-d8
Molecular Formula : C14H15D8NO
-
Sarmentine-d8
Molecular Formula : C14H15D8NO
-
Sarolaner
Molecular Formula : C23 H18 Cl2 F4 N2 O5 S
-
Sarolaner
Molecular Formula : C23 H18 Cl2 F4 N2 O5 S
-
Sarolaner
Molecular Formula : C23 H18 Cl2 F4 N2 O5 S
-
Sarpogrelate Hydrochloride
Molecular Formula : C24H31NO6.ClH
-
Sarpogrelate Hydrochloride
Molecular Formula : C24H31NO6.ClH
-
Sarpogrelate Hydrochloride
Molecular Formula : C24H31NO6.ClH
-
SARS-CoV-2 (Omicron) Neutralizing Antibody Standard
The product is specific for SARS-CoV-2 RBD domain. The product can neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Gamma, Delta, Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5.
-
SARS-CoV-2 (Omicron) Neutralizing Antibody Standard
The product is specific for SARS-CoV-2 RBD domain. The product can neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Gamma, Delta, Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5.
-
SARS-CoV-2 ADE-Causing Antibody (S9HC)
GenScript SARS-CoV-2 ADE-Causing Antibody (S9HC) reacts with SARS-CoV-2 Spike protein of wild type and delta variant. It can obviously enhance the SARS-COV-2 binding with ACE2.
-
SARS-CoV-2 ADE-Causing Antibody (S9HC)
GenScript SARS-CoV-2 ADE-Causing Antibody (S9HC) reacts with SARS-CoV-2 Spike protein of wild type and delta variant. It can obviously enhance the SARS-COV-2 binding with ACE2.
-
SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (6D11F2), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (6D11F2), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (BS-M0220), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (BS-M0220), mAb, Mouse
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
-
SARS-CoV-2 Neutralizing Antibody (R323IgM), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain. The product can recognize and neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Delta, and Omicron. Reactivity with Gamma variant has not been tested.
-
SARS-CoV-2 Neutralizing Antibody (R323IgM), Human Chimeric
The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain. The product can recognize and neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Delta, and Omicron. Reactivity with Gamma variant has not been tested.
-
SARS-CoV-2 Neutralizing Antibody Standard
The product is specific for SARS-CoV-2 RBD domain.The product can neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Gamma, Delta, but can’t neutralize Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5.
-
SARS-CoV-2 Neutralizing Antibody Standard
The product is specific for SARS-CoV-2 RBD domain.The product can neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Gamma, Delta, but can’t neutralize Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5.
-
SARS-CoV-2 Nucleocapsid Antibody (23F2), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (23F2), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (3F9), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (3F9), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (4H2), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (4H2), mAb, Mouse
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (N22IgA), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid Antibody (N22IgA), Human Chimeric
The product is specific for SARS-CoV-2 Nucleocapsid protein.
-
SARS-CoV-2 Nucleocapsid protein
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.
-
SARS-CoV-2 Nucleocapsid protein
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.
-
SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid. The sublineage B.1.617.2 has been redesignated as a “variant of concern” (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.
-
SARS-CoV-2 Nucleocapsid Protein (D63G, R203M, D377Y), His Tag
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid. The sublineage B.1.617.2 has been redesignated as a “variant of concern” (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.
-
SARS-CoV-2 Nucleocapsid protein (G204R, R203K), His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein. -
SARS-CoV-2 Nucleocapsid protein (G204R, R203K), His Tag
SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein.